Primary Hyperparathyroidism in Patients with Multiple Endocrine Neoplasia Type 1
2010

Primary Hyperparathyroidism in MEN-1 Syndrome

publication Evidence: moderate

Author Information

Author(s): Grzegorz Piecha, Jerzy Chudek, Andrzej Więcek

Primary Institution: Medical University of Silesia

Hypothesis

Primary hyperparathyroidism may occur as part of an inherited syndrome known as Multiple Endocrine Neoplasia type 1 (MEN-1).

Conclusion

The diagnosis of MEN-1-associated primary hyperparathyroidism should be confirmed by genetic testing, and surgery remains the main method of management despite a high recurrence rate.

Supporting Evidence

  • Primary hyperparathyroidism is the most frequent clinical presentation of MEN-1, appearing usually in the second decade of life.
  • About 90% of MEN-1 mutation carriers present with primary hyperparathyroidism.
  • Regular screening for hyperparathyroidism is recommended every 1–3 years for MEN-1 mutation carriers.

Takeaway

Some people inherit a condition called MEN-1 that can cause problems with their parathyroid glands, leading to high calcium levels and other health issues. Doctors recommend regular check-ups and sometimes surgery to help manage these problems.

Methodology

The paper reviews the pathomechanism, screening procedures, diagnosis, and management of primary hyperparathyroidism in MEN-1 syndrome.

Limitations

Routine testing for MEN-1 mutations is not recommended for all young patients with primary hyperparathyroidism due to the rarity of these mutations.

Digital Object Identifier (DOI)

10.1155/2010/928383

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication